Insider trades
Aziz Mottiwala, Chief Officer of Tarsus Pharmaceuticals TARS, has filed 0 purchases and 18 sales on the open market. Over the past 12 months that comes to a net sale of $892.5K. The latest trade was on 03/19.
Aziz Mottiwala
Chief Commercial Officer
- Company
- Tarsus Pharmaceuticals TARS
- First filing
- 23/03/10
- Trades
- 40 trades
- Buys / sales
- 0 / 18
- 12-month net buying
- −$892.5K
- Last trade
- 03/19
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
TARS | Open-market sale | 03/17–03/19 | 03/19 | 13,056 sh3 trades | $68.36avg. | $892,528.42 | −17.5% |
| Open-market sale10b5-1 plan | 25/06/09 | 25/06/11 | 17,500 sh | $43.76 | $765,800 | −26.9% | |
TARS | Open-market sale | 25/03/18–25/03/20 | 25/03/20 | 10,565 sh3 trades | $47.88avg. | $505,856.42 | −14.0% |
| Open-market sale | 24/03/18 | 24/03/19 | 4,766 sh | $30.60 | $145,839.6 | −8.1% | |
| Open-market sale10b5-1 plan | 23/07/19 | 23/07/21 | 2,400 sh | $20.05 | $48,120 | −5.0% | |
| Open-market sale10b5-1 plan | 23/06/08 | 23/06/12 | 100 sh | $20.00 | $2,000 | −0.2% | |
TARS | Open-market sale10b5-1 plan | 23/06/06–23/06/07 | 23/06/08 | 4,643 sh2 trades | $19.00avg. | $88,231.23 | −8.8% |
TARS | Open-market sale | 23/03/21–23/03/23 | 23/03/23 | 1,078 sh3 trades | $12.55avg. | $13,530.89 | −2.0% |
TARS | Open-market sale | 23/03/17–23/03/20 | 23/03/21 | 697 sh2 trades | $12.94avg. | $9,016.3 | −1.3% |
| Open-market sale | 23/03/16 | 23/03/17 | 336 sh | $13.43 | $4,512.48 | −0.6% |